China SXT Pharmaceuticals, Inc.
SXTC
$4.10
$0.8024.30%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 102.57% | 0.00% | -154.65% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 245.34% | 0.00% | -61.30% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00% |
| Total Other Non-Cash Items | 0.00% | -120.48% | 0.00% | 356.05% | 0.00% |
| Change in Net Operating Assets | 0.00% | -40.80% | 0.00% | -340.37% | 0.00% |
| Cash from Operations | 0.00% | -29.23% | 0.00% | -77.35% | 0.00% |
| Capital Expenditure | -- | -- | -- | -- | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 64.70% | 0.00% | -- | -- |
| Cash from Investing | 0.00% | 64.70% | 0.00% | -4,120.00% | 0.00% |
| Total Debt Issued | 0.00% | -30.42% | 0.00% | -0.78% | 0.00% |
| Total Debt Repaid | 0.00% | -126.34% | 0.00% | 93.73% | 0.00% |
| Issuance of Common Stock | 0.00% | 75.89% | 0.00% | 87.66% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00% |
| Cash from Financing | 0.00% | 68.73% | 0.00% | 362.22% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 35.65% | 0.00% | 164.50% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 127.47% | 0.00% | 900.21% | 0.00% |